MT-ND4 and Leber hereditary optic neuropathy: Published studies of clinical trials of genes designed to compensate for the mitochondrial complex 1 defect with the functional wild-type gene with intravitreal injection of AAV2-ND4 in ND4-LHON patients reported clinically meaningful beneficial effects beyond the expected natural history of the disease [125].